Alpha-Interferon Inhibits Spontaneous and Induced DNA Synthesis in Hairy Cell Leukemia

References

• Hassan I. B., Sundström C., Hagberg H. Bone marrow morphology during alpha-interferon treatment in hairy cell leukemia. Eur. J. Haematol. 1989; 43: 120–126
   PubMed Web of Science ®Google Scholar
• Hagberg H., Aim G., Bjorkholm M., Glimelius B., Killander A., Simonsson B., Sundstrom C., Ahre A. Alpha interferon treatment of patients with hairy cell leukemia. Scand. J. Hematol 1985; 35: 66–70
   PubMedGoogle Scholar
• Quesada J. R., Reuben J., Manning J. T., Hersh E. M., Gutterman U. G. Alpha interferon for induction of remission in hairy cell leukemia. Scand. J. Med. 1984; 310: 15–18
   Web of Science ®Google Scholar
• Golomb H. M., Fefer A., Golde D. W., Ozer Portlock H., Rappaport C. J., Ratain M. J., Thompson J., Bonnem E. M., Spiegel R. J., Tensen L., Burke J. S., Vardiman J. W. Sequential evaluation of alpha 2b-interferon treatment in 128 patients with hairy cell leukemia. Semin. Oncol 1987; 14: 13–17
   PubMed Web of Science ®Google Scholar
• Gewert D. R., Shah S., Clemens M. J. Inhibition of cell division by interferons; changes in the transport and intracellular metabolism of thymidine in human lympho-blastoid (Daudi) cells. Eur. J. Biochem. 1981; 116: 487–492
   PubMedGoogle Scholar
• Borden E. C., Hogan T. F., Voelkel J. G. Comparative antiproliferative activity in vitro of natural interferons alpha and beta for diploid and transformed human cells. Cancer Res. 1982; 42: 4948–4953
   PubMed Web of Science ®Google Scholar
• Herberman R. B., Djeu J. Y., Ortaldo J. R., Hollden H. T., West W. H., Bonnard G. D. Role of interferon in augmentation of natural and antibody dependent cell-mediated cytotoxicity. Cancer Treat. Rep. 1978; 62: 1893–1896
   PubMedGoogle Scholar
• Huber C., Aulitzky W., Tilg H., Luttichau I. V., Troppmair J., Nachbour K., Gastl G. Studies on the optimal dose and the mode of action of α-interferon in the treatment of hairy cell leukemia. Leukemia 1987; 1(4)355–357
   PubMed Web of Science ®Google Scholar
• Schwarzmeier J. D., Schwabe M., Wagner L., Prischl F. Effect of α2-interferon on hairy cell leukemia and cell lines: A role for type 1 interferon receptors and RNA synthesis. Leukemia 1987; 1(4)361–365
   PubMed Web of Science ®Google Scholar
• Samuels B. L., Rosner M. G., Giometti C. S., Golomb H. M., Brownstein B. H. Action of interferons in hairy cell leukemia. Leukemia 1987; 1(4)365–369
   PubMed Web of Science ®Google Scholar
• Samuels B. L., Golomb H. M., Brownstein B. H. In vitro induction of proteins by alpha-interferon in hairy cell leukemia. Cancer Res. 1986; 46: 4151–4155
   PubMed Web of Science ®Google Scholar
• Samuels B. L., Golomb H. M., Brownstein B. H. In vivo induction of proteins during therapy of hairy cell leukemia with alpha-interferon. Blood 1987; 69(6)1570–1573
   PubMed Web of Science ®Google Scholar
• Hiraoka A., Rosner M. C., Golomb H. M. In vitro response of cells from three patients with hairy cell leukemia to a recombinant leukocyte interferon. Virchow Arch [Cell pathol] 1985; 49: 73–82
   Google Scholar
• Griffiths S. D., Cawley J. C. The beneficial effect of a-interferon in hairy cell leukemia are not attributable to NK cell-mediated cytotoxicity. Leukemia 1987; 1(4)374–376
   Google Scholar
• Ruco L. P., Procopio A., Maccallini V., Calogero A., Uccini S., Annino L., Mandelli F., Baroni C. Severe deficiency of natural killer activity in the peripheral blood of patients with hairy cell leukemia. Blood 1983; 61(6)1132–1137
   PubMed Web of Science ®Google Scholar
• Hooper W. C., Barth R. F., Shah N. T. Lack of natural killer activity in hairy cell leukemia patients and partial restoration with interleukin-2. Cancer 1986; 57: 988–993
   PubMed Web of Science ®Google Scholar
• Semenzato Pizzolo G. G., Agostini C., Zambello R., Trentin L., Luca M., Masciarelli M., Chilosi M., Vinante F., Perona G., Getto G. α-interferon activates natural killer system in patients with hairy cell leukemia. Blood 1986; 68(1)293–296
   PubMed Web of Science ®Google Scholar
• Terntin L., Zambello R., Agostini C., Ambrosetti A., Chisesi T., Raimondi R., Bulian P., Pizzolo G., Semenzato G. Mechanisms accounting for the defective natural killer activity in patients with hairy cell leukemia. Blood 1990; 75(7)1525–1530
   PubMed Web of Science ®Google Scholar
• Cordingley F. T., Hoffbrand A. V., Brenner M. K. Cytokine induced enhancement of the hairy cell leukemia lymphocytes to natural killer cell lysis. Brit. J. Haematol 1988; 70: 37–41
   PubMed Web of Science ®Google Scholar
• Cordingley F. T., Hoffbrand A. V., Heslop H. E., Turner M., Bianchi A., Reittie J. E., Vyakarnam A., Meager A. Tumour necrosis factor as an autocrine tumour growth factor for chronic BL-cell malignancies. Lancet 1988; i: 969–971
   Google Scholar
• Bianchi A. C. M., Heslop H. E., Drexler H. G., Cordingley F. T., De Mel W. C. P., Hoffbrand A. V., Brenner M. K. Effect of tumour necrosis factor and interferon on chronic B cell malignancies. Nouv. Rev. Fr. Hematol 1988; 30: 317–319
   PubMedGoogle Scholar
• Digel W., Stefanic M., Schöniger W., Buck C., Raghavachar A., Frickhofen N., Heimpel H., Porzsolt F. Tumour necrosis factor induces proliferation of neoplastic B cells from chronic lymphocytic leukemia. Blood 1989; 73(5)1242–1246
   PubMed Web of Science ®Google Scholar
• Visser L., Slupsky A. J., Vos H., Poppema S. Monoclonal antibody reactive with hairy cell leukemia. Blood 1989; 74: 320
   PubMed Web of Science ®Google Scholar
• Cordell J., Falini B., Erber W. N., Ghosh A. K., Abdulaziz Z., Macdonald S., Pulford K. A. F., Stein H., Mason D. Y. Immunoenzymatic labelling of monoclonal antibodies using immunocomplexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J. Hislochem. & Cytochem. 1984; 32(2)219–229
   PubMed Web of Science ®Google Scholar
• Rogers A. W. Techniques of Autoradiography, 3rd ed. Elsevier/North-Holland, New York 1979
   Google Scholar
• Darzynkiewicz Z. Acridine orange as a molecular probe in studies of nucleic acids in situ. Flow cytometry and sorting, M. R. Melamed, M. Mendelsohn, P. Mullaney. Wiley, New York 1979; 285–316
   Google Scholar
• Einhorn S., Strander H. Interferon therapy for neoplastic diseases in man. Human interferon production and clinical use, W. J. Stinebring, P. J. Chappie. Plenum Publishing Corp., New York 1977; 159–174
   Google Scholar
• Bradley E. C., Ruscecetti F. W. Effect of fibroblast, lymphoid and myeloid interferons on human tumour colony formation. Cancer Res. 1981; 41: 244–249
   PubMed Web of Science ®Google Scholar
• Einhorn S., Strander H. Is interferon tissue specific? Effect of human leukocyte and fibroblast interferons on the growth of lymphoblastoid and osteosarcoma cell lines. J. Gen. Virol. 1977; 35: 573–577
   PubMed Web of Science ®Google Scholar
• Roos G., Leanderson T., Lundgren E. Interferon-induced cell cycle changes in human hematopoietic cell lines and fresh leukemic cells. Cancer Res. 1984; 44: 2358–2362
   PubMed Web of Science ®Google Scholar
• Robert K.-H., Einhorn S., Juliusson G., Ostlund L., Biberfeld P. Interferon induces proliferation and differentiation in primary chronic lymphocytic leukemia cells. Clin. Exp. Immunol. 1985; 62: 530–534
   PubMed Web of Science ®Google Scholar
• Ostlund L., Einhorn S., Robert K.-H., Juliusson G., Biberfeld P. Chronic B-lymphocytic leukemia cells proliferate and differentiate following exposure to interferon in vitro. Blood 1986; 67: 152–159
   PubMed Web of Science ®Google Scholar
• Ostlund L., Biberfeld P., Robert K.-H., Christensson B., Einhorn S. Induction of proliferation and blast transformation by interferon in human malignant and non-malignant lymph node B cells. Blood 1989; 73(8)2171–2181
   PubMed Web of Science ®Google Scholar
• Karray S., Delfraissy J.-F., Merle-Beral H., Wallon C., Debre P., Galanaud P. Positive effects of interferon-a on B-cell type chronic lymphocytic leukemia proliferative response. J. Immunol. 1988; 140: 0774–0778
   PubMed Web of Science ®Google Scholar
• Paganelli K. A., Evans S. S., Han T., Ozer H. B cell growth factor-induced proliferation of hairy cell lymphocytes and inhibition by type 1 interferon in vitro. Blood 1986; 67(4)937–942
   PubMed Web of Science ®Google Scholar
• Barut B. A., Cochran M. K., O'Hara C., Anderson K. C. Response patterns of hairy cell leukemia to B-cell mitogens and growth factors. Blood 1990; 76(10)2091–2097
   PubMed Web of Science ®Google Scholar
• Buck G., Digel W., Schoniger W., Stefantic M., Raghavachar A., Heimpel H., Porzsolt F. Tumour necrosis factor-a, but not lymphotoxin, stimulates growth of tumor cells in hairy cell leukemia. Leukemia 1990; 4(6)431–434
   PubMed Web of Science ®Google Scholar
• Bello L. J. Regulation of thymidine kinase synthesis in human cells. Exptl. Cell Res. 1947; 89: 263–274
   Web of Science ®Google Scholar
• Hagberg H., Glimelius B., Gronowitz S., Killander A., Kallander C., Schroder T. Biochemical markers in non-Hodgkin's lymphoma stage III and IV and prognosis. Scand. J. Haematol. 1984; 33: 59–67
   PubMedGoogle Scholar
• Gronowitz S., Hagberg H., Kallander C. F. R., Simonsson B. The use of serum deoxythymidine kinase as a prognostic marker and monitoring of patients with non-Hodgkin's lymphoma. Br. J. Cancer 1983; 47: 487–498
   PubMed Web of Science ®Google Scholar
• Ellims P. H., Eng Gan T., van der Weyden N. B. Fetal thymidine kinase (TK1) in hairy cell leukemia. Scand. J. Haematol. 1983; 30: 141–144
   PubMedGoogle Scholar
• Hagberg H., Hassan I. B., Glimelius B., Gronowitz S., Kallander C., Martinsson U., Sundstrom C. Serum thymidine kinase in hairy cell leukemia before and during treatment with alpha interferon. Haematologica 1988; 73: 365–369
   PubMedGoogle Scholar